Hematologic and clinical responses of thalassemia intermedia patients to hydroxyurea during 6 years of therapy in Iran

Journal of Pediatric Hematology/Oncology

Volumn 27, Issue 7, 2005, Pages 380-385

  Karimi, Mehran ^a   Darzi, Hadi ^a   Yavarian, Majid ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hematologix and clinical response; Hydroxyurea; Southern Iran; Thalassemia intermedia

Indexed keywords

HEMOGLOBIN; HYDROXYUREA;

ADOLESCENT; ADULT; BETA THALASSEMIA; BLOOD TRANSFUSION; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ELECTROPHORESIS; EXERCISE TOLERANCE; FATIGUE; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; IRAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MOOD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPLEEN SIZE;

ADOLESCENT; ADULT; ANTISICKLING AGENTS; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HEMOGLOBINS; HUMANS; HYDROXYUREA; INFANT; IRAN; LEUKOCYTE COUNT; MALE; PLATELET COUNT; RETROSPECTIVE STUDIES; THALASSEMIA;

EID: 23044442033     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mph.0000174386.13109.28     Document Type: Conference Paper

References (20)

1. Weatherall DJ. The thalassemias. In: Stamatoyannopoulos G, Nienthuis AW, eds. The Molecular Basis of Blood Diseases, 2nd ed. Philadelphia: WB Saunders, 1994:157.
2. Zeng YT, Huang SZ, Ren ZR, et al. Hydroxyurea therapy in β-thalassemia intermedia: improvement in hematological parameters due to enhanced β-globin synthesis. Br J Hematol. 1995;90:557-563.
3. Letvin NLDC, Linch P, Bearssky KW, et al. Augmentation of fetal hemoglobin production in anemic monkeys by hydroxyurea. N Engl J Med. 1984;310:317-323.
4. Vetthi RR, Galanello TH, Para Yannopoulou G, et al. Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea. N Engl J Med. 1995;213:1571-1575.
5. Konstantopoulos KG, Vagiopoulos R, Kantouni S, et al. A case of spinal compression by extramedullary hemopoiesis in a thalassemic patient: a putative role for hydroxyurea. Haematologica. 1992;77:352-354.
6. Loukopoulos D, Voskaridou E, Stamoulakatou A, et al. Hydroxyurea therapy in thalassemia. Ann NY Acad Sci. 1998;850:120-128.
7. Voskaridou B, Kalotychou V, Houkopoulos D. Clinical and laboratory effects of long-term administration of hydroxyurea to patients with sickle-cell β-thalassemia. Br J Hematol. 1995;89:479-484.
8. Cohen AR, Martin MB, Schwartz E. Hydroxyurea therapy in thalassemia intermedia. In: Beuzard Y, Lubin B, Rosa J, eds. Sickle Cell Disease and Thalassemias: New Trends in Therapy. London: John Libbey Eurotext. 1995:193.
9. Sher GD, Ginder GD, Little J. et al. Extended therapy with intravenous arginine butyrate in patients with β-hemoglobinopathies. N Engl J Med. 1995;332:1606.
10. Charache S, Barton FB, Moore RD, et al. Hydroxyurea and sickle cell anemia. Medicine. 1996;75:300-326.
11. Anselm GW, Tai KS, Wong VP, et al. Hypertransfusion for spinal cord compression secondary to extramedullary hematopoiesis. Pediatr Hematol Oncol. 1996;13:89-94.
12. Saxon BR, Rees D, Dlivieri NF. Regression of extramedullary hemopoiesis and augmentation of fetal hemoglobin concentration during hydroxyurea therapy in β-thalassemia. Br J Hematol. 1998;101:416-419.
13. Cianciulli P, di Toritto TC, Sorrentino F, et al. Hydroxyurea therapy in paraparesis and cauda equina syndrome due to extramedullary hematopoiesis in thalassemia: improvement of clinical and hematological parameters. Eur J Haematol. 2000;64:426-429.
14. Hoppe C, Vichinsky E, Lewis B, et al. Hydroxyurea and sodium phenylbutyrate therapy in thalassemia intermedia. Am J Hematol. 1999; 62:221-227.
15. Styles L, Lewis B, Foote D, et al. Preliminary report: hydroxyurea produces significant response in thalassemia intermedia. Ann NY Acad Sci. 1998;850:461-462.
16. Hajjar FM, Pearson HA. Pharmacologic treatment of thalassemia intermedia with hydroxyurea. J Pediatr. 1994;125:490-492.
17. Karimi M, Yarmohammadi H, Farjadian S, et al. β-thalassemia intermedia from southern Iran: IVS-II-I (G→A) is the prevalent thalassemia intermedia allele. Hemoglobin. 2002;26:147-154.
18. De Franceschi L, Fessard PR, Alper SL, et al. Combination therapy of erythropoietin, hydroxyurea and clotrimazole in a β-thalassemic mouse. Blood. 1996;87:1188-1195.
19. Fibach P, Burke LP, Schechter AN, et al. Hydroxyurea increases fetal hemoglobin in cultured erythroid cells derived from normal individuals and patients with sickle cell anemia or β-thalassemia. Blood. 1993;81: 1630-1635.
20. Kollia P, Fibacb E, Politou M, et al. Hydroxyurea and hemin affect both the transcriptional and post-transcriptional mechanisms of some globin genes in human adult erythroid cells. Ann NY Acad Sci. 1998;850: 446-448.